![Rod Ferguson](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Rod Ferguson
Direttore/Membro del Consiglio presso
AUSPEX PHARMACEUTICALS INC
Profilo
Rod A. Ferguson is the founder of Panorama Capital LLC, founded in 2005, serving as Managing Director since 2006.
Current jobs include Independent Director at Auspex Pharmaceuticals, Inc. since 2013 and Independent Director at Launch One Acquisition Corp.
since 2024.
Former jobs include Chairman at Anesiva, Inc. from 2000 to 2009, Chairman at Presidio Pharmaceuticals, Inc. in 2009, Senior Director-Business & Corporate Development at Genentech, Inc. from 1988 to 1999, Director roles at Kémia, Inc., Alvine Pharmaceuticals, Inc., Itero Biopharmaceuticals, Inc., AlgoRx Pharmaceuticals, Inc., Hercules Capital, Inc., and CardioKinetix, Inc., General Partner at J.P.
Morgan Partners LLC from 2001 to 2004, Associate at McCutchen, Doyle, Brown & Enersen LLP, and General Partner at InterWest Venture Management Co. from 1999 to 2000.
Education includes a graduate degree from Northwestern University in 1984, a doctorate from the State University of New York at Buffalo in 1981, and an undergraduate degree from the University of Illinois in 1977.
Posizioni attive di Rod Ferguson
| Società | Posizione | Inizio |
|---|---|---|
| AUSPEX PHARMACEUTICALS INC | Direttore/Membro del Consiglio | 01/01/2013 |
Panorama Capital LLC
 Panorama Capital LLC Investment ManagersFinance Panorama Capital invests in companies located in the United states. The firm targets companies operating in the fields of life sciences, internet infrastructure & services and semiconductors. It provides financing for seed, early and later stage capital requirements with an investment size ranging from USD 5 - 20 million. | Fondatore | 01/01/2006 |
Precedenti posizioni note di Rod Ferguson
| Società | Posizione | Fine |
|---|---|---|
Anesiva, Inc.
 Anesiva, Inc. Pharmaceuticals: MajorHealth Technology Develops pharmaceutical products for pain management | Presidente | 31/03/2009 |
J.P. Morgan Partners LLC
 J.P. Morgan Partners LLC Investment ManagersFinance J.P. Morgan Partners provides financing for growth capital, corporate acquisitions, LBOs, special situations and recapitalizations. The firm invests globally across a variety of sectors including consumer, media, energy, industrial, financial services, healthcare and technology | Investitore di Private Equity | 31/12/2004 |
Interwest Venture Management Co.
 Interwest Venture Management Co. Investment ManagersFinance InterWest Venture invests in companies located in the United States. The firm focuses on healthcare and information technology. It participates in early stage transactions. It also acts as a lead investor and takes a seat on the board. | Corporate Officer/Principal | 31/12/2000 |
Genentech, Inc.
 Genentech, Inc. BiotechnologyHealth Technology Operates as a biotechnology company that develops medicines for cancer peoples | Corporate Officer/Principal | 01/01/1999 |
AlgoRx Pharmaceuticals, Inc.
 AlgoRx Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Develops pharmaceutical drugs for pain management | Direttore/Membro del Consiglio | - |
Formazione di Rod Ferguson
Esperienze
Posizioni ricoperte
Attive
Inattive
Società nel listino
Aziende private
Relazioni
89
Relazioni di 1° grado
17
Aziende connesse in 1º grado
Uomo
Donna
Amministratori
Dirigenti
Società collegate
| Aziende private | 17 |
|---|---|
Genentech, Inc.
Genentech, Inc. BiotechnologyHealth Technology Operates as a biotechnology company that develops medicines for cancer peoples | Health Technology |
Kémia, Inc.
 Kémia, Inc. Pharmaceuticals: MajorHealth Technology Discovers and develops novel small molecule therapeutics | Health Technology |
Anesiva, Inc.
Anesiva, Inc. Pharmaceuticals: MajorHealth Technology Develops pharmaceutical products for pain management | Health Technology |
Alvine Pharmaceuticals, Inc.
 Alvine Pharmaceuticals, Inc. Medical SpecialtiesHealth Technology Develops and commercializes therapeutics for inflammatory diseases | Health Technology |
Itero Biopharmaceuticals, Inc.
 Itero Biopharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Develops biopharmaceutical products for novel therapeutic proteins and antibodies | Health Technology |
J.P. Morgan Partners LLC
J.P. Morgan Partners LLC Investment ManagersFinance J.P. Morgan Partners provides financing for growth capital, corporate acquisitions, LBOs, special situations and recapitalizations. The firm invests globally across a variety of sectors including consumer, media, energy, industrial, financial services, healthcare and technology | Finance |
AlgoRx Pharmaceuticals, Inc.
AlgoRx Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Develops pharmaceutical drugs for pain management | Health Technology |
McCutchen, Doyle, Brown & Enersen LLP
 McCutchen, Doyle, Brown & Enersen LLP Miscellaneous Commercial ServicesCommercial Services Provides legal services | Commercial Services |
Northwestern University
 Northwestern University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
State University of New York at Buffalo
 State University of New York at Buffalo Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
University of Illinois
 University of Illinois Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Hercules Capital, Inc.
 Hercules Capital, Inc. Finance/Rental/LeasingFinance Provides financing solutions to high-growth and innovative venture capital-backed and institutional-backed companies | Finance |
Panorama Capital LLC
Panorama Capital LLC Investment ManagersFinance Panorama Capital invests in companies located in the United states. The firm targets companies operating in the fields of life sciences, internet infrastructure & services and semiconductors. It provides financing for seed, early and later stage capital requirements with an investment size ranging from USD 5 - 20 million. | Finance |
Presidio Pharmaceuticals, Inc.
 Presidio Pharmaceuticals, Inc. BiotechnologyHealth Technology Discovers and develops small-molecule antiviral therapeutics | Health Technology |
CardioKinetix, Inc.
 CardioKinetix, Inc. Medical SpecialtiesHealth Technology Develops ventricular partitioning device for heart failure disease | Health Technology |
Auspex Pharmaceuticals, Inc.
 Auspex Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Operates as a biopharmaceutical company | Health Technology |
Interwest Venture Management Co.
Interwest Venture Management Co. Investment ManagersFinance InterWest Venture invests in companies located in the United States. The firm focuses on healthcare and information technology. It participates in early stage transactions. It also acts as a lead investor and takes a seat on the board. | Finance |
